Curis highlights progress in lymphoma and AML trials with expanded patient enrollment

Stock Information for Curis Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Curis Inc.

Curis Provides Updated Data from its Frontline AML Triplet Study
Curis to Present at Upcoming 30th Annual SNO Meeting
Curis Provides Third Quarter 2025 Business Update
Curis to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on November 6, 2025
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Curis to Present at Upcoming Healthcare Conferences in September
Curis Provides Second Quarter 2025 Business Update
Curis to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on August 5, 2025

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.